Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

Laser laparoscopy effectively reduces pelvic pain in women with mild to moderate endometriosis and is safe to use.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Oral contraceptives may cause hair loss in women.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Hormonal therapies are safe and effective for treating adult women's acne.

Certain hormone treatments can improve acne and related conditions in women.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.